These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2098653)

  • 1. [The role of opioid antagonists in the treatment of obesity. Results of a clinical trial with naltrexone].
    Novi RF; Lamberto M; Visconti P; Maurino M; Ardizzone A; Mantovan M; Meluzzi A; Francesetti G; Molinatti GM
    Minerva Endocrinol; 1990; 15(2):121-3. PubMed ID: 2098653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naltrexone double blind placebo controlled study in Israel.
    Lerner A; Sigal M; Bacalu A; Shiff R; Burganski I; Gelkopf M
    Isr J Psychiatry Relat Sci; 1992; 29(1):36-43. PubMed ID: 1568861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of a combination medication for the treatment of obesity.
    Greenway FL; Whitehouse MJ; Guttadauria M; Anderson JW; Atkinson RL; Fujioka K; Gadde KM; Gupta AK; O'Neil P; Schumacher D; Smith D; Dunayevich E; Tollefson GD; Weber E; Cowley MA
    Obesity (Silver Spring); 2009 Jan; 17(1):30-9. PubMed ID: 18997675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage.
    Pfohl DN; Allen JI; Atkinson RL; Knopman DS; Malcolm RJ; Mitchell JE; Morley JE
    NIDA Res Monogr; 1986; 67():66-72. PubMed ID: 3092099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.
    Cuellar GE; Ruiz AM; Monsalve MC; Berber A
    Obes Res; 2000 Jan; 8(1):71-82. PubMed ID: 10678261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
    Johnson BA; Ait-Daoud N; Prihoda TJ
    Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of naltrexone in obese humans.
    Malcolm R; O'Neil PM; Sexauer JD; Riddle FE; Currey HS; Counts C
    Int J Obes; 1985; 9(5):347-53. PubMed ID: 3908352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
    Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
    Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
    Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
    Garrison R; Chambliss WG
    Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of naltrexone in premenstrual syndrome.
    Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
    King A; de Wit H; Riley RC; Cao D; Niaura R; Hatsukami D
    Nicotine Tob Res; 2006 Oct; 8(5):671-82. PubMed ID: 17008194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.